Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1999
06/15/1999US5911997 Relaxin-like factor and methods and uses thereof
06/15/1999US5911995 EGF-genistein conjugates for the treatment of cancer
06/15/1999US5911991 Malarial binding site in duffy blood group protein
06/15/1999US5911990 Restoring normal immune response by administering peptide which stimulates production of interferon-gamma and interleukin-5 while suppressing production of immunoglobulin-g and interleukins-5,-6 and-10
06/15/1999US5911989 Antibodies
06/15/1999US5911988 Method for treating asthma using SCF antibody
06/15/1999US5911984 Disorders associated with fatty acid metabolism.
06/15/1999US5911704 For delivering a pre-selected molecule into systemic circulation
06/15/1999CA2201749C Stable aqueous alfa interferon solution formulations
06/15/1999CA2128612C Antimicrobial agents and method for treating products therewith
06/15/1999CA2088068C Protein structure of the plant toxin gelonin
06/15/1999CA2055827C Solutions for the perfusion, preservation and reperfusion of organs
06/15/1999CA2014465C Herpesvirus recombinant poxvirus vaccine
06/15/1999CA2000307C Production of hydrogen peroxide
06/10/1999WO1999028876A2 Hydrophobically-modified protein compositions and methods
06/10/1999WO1999028753A1 Application of tryptophan hydroxylase, a novel autoantigen, in immunoassays, drug production and treatment
06/10/1999WO1999028750A1 Frnk proteins in the treatment of tumor cells
06/10/1999WO1999028749A1 USES OF p27 IN PROSTATE CANCER
06/10/1999WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant
06/10/1999WO1999028478A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
06/10/1999WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/10/1999WO1999028474A2 Chemokine variants and methods of use
06/10/1999WO1999028473A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028472A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028470A1 G-protein coupled receptors and uses therefor
06/10/1999WO1999028469A1 Compositions and methods for inducing gene expression
06/10/1999WO1999028468A1 Modulating b lymphocyte chemokine/receptor interactions
06/10/1999WO1999028466A1 Compositions and methods of use of het
06/10/1999WO1999028461A2 Methods and means for inducing apoptosis by interfering with bip-like proteins
06/10/1999WO1999028460A2 Molecules interacting with apoptin
06/10/1999WO1999028457A1 Tsa305 gene
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028455A1 Method for preparing polypeptides with appropriate glycosilation
06/10/1999WO1999028454A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
06/10/1999WO1999028452A1 Matrilysin antisense compounds
06/10/1999WO1999028447A1 Human rnase h and compositions and uses thereof
06/10/1999WO1999028444A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
06/10/1999WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
06/10/1999WO1999028348A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
06/10/1999WO1999028346A1 Erythropoietin with high specific activity
06/10/1999WO1999028345A1 Conjugates useful in the treatment of prostate cancer
06/10/1999WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999WO1999028343A2 Hydrophobically-modified protein compositions and methods
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999028341A2 Maintenance of smooth muscle integrity by morphogenic proteins
06/10/1999WO1999028339A1 Backbone cyclic peptide fragments and their analogs derived from pban 1-33, useful as insecticides
06/10/1999WO1999028338A1 Inhibition of nuclear import by backbone cyclic peptide analogs
06/10/1999WO1999028335A1 Secreted proteins and polynucleotides encoding them
06/10/1999WO1999027983A1 A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING OF A VOLUME LESS THAN 0.5 ml
06/10/1999WO1999027967A1 Therapeutic agents
06/10/1999WO1999027964A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999WO1999027955A2 Treatment of established chronic infections and cancers
06/10/1999WO1999027954A2 Mixed lipopeptide micelles for inducing an immune response
06/10/1999WO1999027953A1 Chemoprotective bacterial strains
06/10/1999WO1999027952A1 Anti-hypoxic and anti-ischemic drug
06/10/1999WO1999027951A1 Preparation for continuous intravenous administration
06/10/1999WO1999027950A1 Compositions of leukaemia inhibitory factor
06/10/1999WO1999027949A1 METHOD OF SUPPRESSING β-AMYLOID-RELATED CHANGES IN ALZHEIMER'S DISEASE
06/10/1999WO1999027948A2 Use of soluble recombinant human cd40l protein for inhibiting in vivo immune response
06/10/1999WO1999027947A1 The use of lectin preparations for combating cancers of the bladder
06/10/1999WO1999027946A1 Pharmaceutical composition comprising cyclosporin solid-state microemulsion
06/10/1999WO1999027945A1 Threonine-containing protegrins
06/10/1999WO1999027944A1 Prevention and treatment of amyloidogenic disease
06/10/1999WO1999027941A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999WO1999027927A1 Synergistic antimicrobial compositions
06/10/1999WO1999027918A1 Microparticles for drug delivery across mucosa and the blood-brain barrier
06/10/1999WO1999027913A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
06/10/1999WO1999027912A1 Porous hydroxyapatite particles as carriers for drug substances
06/10/1999WO1999027908A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999WO1999027907A1 Improved method for avoiding the degradation of an active principle
06/10/1999WO1999027897A1 Site-specific preparation of polyethylene glycol-grf conjugates
06/10/1999WO1999015659A3 Human ubiquitin-conjugating enzymes
06/10/1999WO1999015658A3 Human regulatory molecules
06/10/1999WO1999015643A3 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE
06/10/1999WO1999015158A3 REGULATION OF CELLULAR APOPTOSIS USING MODULATORS OF β-AR RECEPTORS
06/10/1999WO1999014241A3 Compositions and methods for the treatment of immune related diseases
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999013067A3 Hypoxia inducible promoter
06/10/1999WO1999012958A3 Ampullosporin, method for producing same and its use
06/10/1999WO1999008701A9 Complexes of apolipoprotein e and ciliary neurotrophic factor (cntf) and methods of use
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999WO1998058955A9 Nuclear matrix targeting peptides and uses therefor
06/10/1999WO1998058052A3 Disease associated protein kinases
06/10/1999WO1998004582A8 Isolated peptides derived from mage-2
06/10/1999DE19754298A1 Organisch-chemische Verbindungen und Verfahren zu ihrer Herstellung Organic chemical compounds and methods for their preparation
06/10/1999DE19754103A1 New packaging cell line for E1-deleted adenovirus
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999DE19752597A1 Verwendung von Lektinzubereitungen bei der Bekämpfung von Harnblasenkarzinomen Use of Lektinzubereitungen in the fight against bladder cancer
06/10/1999CA2314423A1 Maintenance of smooth muscle integrity by morphogenic proteins
06/10/1999CA2313029A1 Improved method for avoiding the degradation of an active principle
06/10/1999CA2313028A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999CA2312920A1 Prevention and treatment of amyloidogenic disease
06/10/1999CA2312847A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2312811A1 Synergistic antimicrobial compositions
06/10/1999CA2312778A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999CA2312478A1 G-protein coupled receptors and uses therefor
1 ... 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 ... 3163